Table 2 Main effects of caffeine administration on neuroinflammatory and behavioral outcomes in animal models of depression.
Author, Year | Depression Model | Animal | Caffeine Exposure | Other Substances | Behavior Test | Inflammatory markers | Other effects |
|---|---|---|---|---|---|---|---|
Mudgal et al. 2019 | LPS (E.coli 0111:B4) 1.5 mg.kg-1, i.p. | Adult Male Swiss albino mice | Caffeine (5 mg.kg-1 gavage Chronic (1 week) | Caffeic acid (CA 10 mg.kg-1) & Imipramina: 15 mg.kg-1 | Caffeic acid + Caffeine: Antidepressant in the TST and FST; Anxiolytic in OFT and DLB. | Caffeic acid + Caffeine: Anti-inflammatory (reduces IL-6, TNFα – serum/ brain) | Caffeic acid + Caffeine: decrease MDA, increase GSH |
Hall et al. [32] | LPS (E. coli O111:B4) 0.83 mg.kg-1, ip. | Adult Male C57BL/6 J mice | Caffeine (10 mg.kg-1) gavage Chronic (2 weeks) | Imipramine (10 mg.kg-1), coffee samples (caffeinated and decaffeinated – 140 mg.kg-1 each); | Caffeinated and decaffeinated coffee: Antidepressant in the TST, FST, and exploratory behavior in OFT. | Caffeinated and decaffeinated coffee - anti-inflammatory (reduces IDO activity, neopterin/biopterin ratio, slightly decreases in the brain concentrations of PGE2) | Neuroprotection - KA/3-HK and KA/KYN ratios |
Mallik et al. 2021 | LPS (E. coli O111:B4) 0.83 mg.kg-1, ip. | Adult Male C57BL/6 J mice | Caffeine (10 mg.kg-1) gavage Chronic (2 weeks) | Imipramine (10 mg.kg-1) | Caffeine: Antidepressant in the TST, FST, and exploratory behavior in OFT. | Caffeine: Anti-inflammatory (reduces IL-6, TNFα, IL-1ß, IFNγ | Caffeine: Reduces lipid peroxidation (decrease MDA); increase BDNF |
Unno et al. [35] | LPS (O55:B5, L2880) 0.5 mg.kg-1, ip. | Adult Male SAMP10/TaIdrSlc mice | Green tea with CE/TA ratios (1, 2, 4, 8, and 12 mole ratio) ~ caffeine at 60,120,120, 240,360 μmole. oral (in the bottle) | CE/TA ratio (CE - 60,120,120, 240,360 μmole) relative to (T - 80,80,40, 40,40 μmole) (A 40,40, 20,20, 20 μmole) | Green tea (CE/TA ratio 4/5): Anti depressant in the SPT; reduces Npas. | Green tea (CE/TA ratio1/2): Anti-inflammatory (reduces TNFα, IL-1ß), | Green tea (CE/TA ratio1/2): Inhibits adrenal hypertrophy and thymic atrophy; suppression of Lcn2 expression |
Zhang et al. [36] | LPS (E. coli O111:B4) 0.83 mg.kg-1, ip. | Adult Male Sprague–Dawley rats | Caffeine (60 mg.kg-1 gavage Chronic (4 weeks). | No | Caffeine: Antidepressant in the TST, FST, OFT, and CFT. | Caffeine: Anti-inflammatory (reduces pAKT, NFkB) | No other effect |
Daubry et al. [37] | Sleep Deprivation | Male Wistar adult rats | Caffeine (200 mg.kg1) Gavage Chronic (4 weeks). | Alcohol - 20% | Caffeine: Anxiogenic (hole-board test and EPM); Decrease social behavior; locomotive activity in the OFT. | Caffeine: increases inflammatory cytokines (TNF-β, IL-6, and IL-10); Decreases AChE activity; | impaired memory (SAB); |
Gu et al. [38] | Chronic paradoxical sleep deprivation (PSD) | Male Wistar adult rats | Conventional coffee – (0.5 ml/100 g) & decaffeinated coffee - (200 mg.kg-1) Gavage (1 week). | No | Conventional and decaffeinated coffee: Antidepressant in the TST, FST, SPT, and OFT. | Conventional coffee: Anti-inflammatory (decreases IL-6 and TNFα); Decaffeinated coffee: Anti-inflammatory (decreases TNFα). | Conventional and decaffeinated coffee: Recovers intestinal dysbiosis; increases SOD, and GSH-Px levels |
Mao et al. [39] | Chronic water immersion restraint stress (CWIRS) (3 weeks) | Adult Male Kunming mice | Caffeine (10, 20 mg.kg-1). gavage Chronic (4 weeks). | CORT (2 mg.kg-1), RU486 (25 mg.kg-1), fluoxetine (20 mg.kg-1), | Caffeine: Antidepressant in the TST, FST, and SPT; Increase 5-HT and decrease 5-HIAA levels. | Caffeine: Anti-inflammatory (suppress microglia activation (IBA1, CD68); reduces NO, TNFα, IL-1ß;pNFkB). | Caffeine: Stimulates neurogenesis (BrdU); reduces p-MEK/MEK, p-ERK1/2/ERK 1/2 e p-NFkB/GPADH ratios |
Markovaa et al. [40] | Social defeat (20 days) | Adult Male C57BL/6 mice | Transplantation of immune cells pre-treated with caffeine at the dose of 100 μg per 15 × 106 cells with 3% FCS (Hyclone) | No | Transplantation of cells treated with caffeine: Antidepressant in the FST, OFT, SPT, and EPM; | Transplantation of cells treated with caffeine: decreases pro-inflammatory cytokines (IL-1β, IL-6, INF-γ, and TNF-α) and increases anti-inflammatory (IL-10 and IL-4). | Transplantation of cells treated with caffeine: Increases BDNF and neurogenesis and/or survival of hippocampal neurons |